A PROOF-OF-CONCEPT STUDY TO EVALUATE THE ADMINISTRATION OF CN105 IN PARTICIPANTS WITH ACUTE SUPRATENTORIAL INTRACEREBRAL HEMORRHAGE Save

Date Added
February 27th, 2018
PRO Number
Pro00072381
Researcher
Charles Andrews

Silhouette
Keywords
Stroke
Summary

This is a study of a new drug (CN105) that has not yet been approved for use in the general population by the FDA. This drug is being used to treat intracranial hemorrhage patients. We are studying the effects of this drug given to these patients to make sure that the drug is safe. This is an important step that all new drugs must go through before they are approved for use by the FDA. To determine if this drug is safe, we will be following the outcomes of patients that receive this new drug for the first 90 days after receiving it.

Institution
MUSC
Recruitment Contact
Cheryl Grant
843-792-7118
grantche@musc.edu

Change_preferences

-- OR --

Create_login